Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Language
Publication year range
1.
An Acad Bras Cienc ; 91(3): e20180621, 2019 Aug 12.
Article in English | MEDLINE | ID: mdl-31411258

ABSTRACT

Aristolochia triangularis Cham., is one of the most frequently used medicinal plant in Southern Brazil. Preparations containing the leaves and/or stems are traditionally used as anti-inflammatory, diuretic, as well as antidote against snakebites. This study screened A. triangularis extracts, fractions and isolated compounds for different bioactivities. A weak antiproliferative activity against human lung cancer cell line (A549) was observed only for chloroform fraction obtained from stems (CFstems - CC50: 2.93 µg/mL). Also, a moderate antimicrobial activity against Staphylococcus aureus was detected just for chloroform fraction obtained from leaves (CFleaves -13-16 mm inhibition zone). Additionally, two semi-purified fractions (CFstems-4 and CFleaves-4) selectively inhibited HSV-1 replication (IC50 values of 0.40 and 2.61 µg/mL, respectively), while only CFleaves showed promising results against Leishmania amazonensis. Fractionation of extracts resulted in the isolation of one neolignan (-) cubebin and one lignan (+) galbacin. However, these compounds are not responsible for the in vitro bioactivities herein detected. The presence of aristolochic acid I and aristolochic acid II in the crude ethanol extract of stems (CEEstems) and leaves (CEEleaves) was also investigated. The HPLC analysis of these extracts did not display any peak with retention time or UV spectra comparable to aristolochic acids I and II.


Subject(s)
Aristolochia/chemistry , Phytochemicals/chemistry , Anti-Bacterial Agents/pharmacology , Antifungal Agents/pharmacology , Antiprotozoal Agents/pharmacology , Antiviral Agents/pharmacology , Aristolochic Acids/chemistry , Brazil , Chemical Fractionation , Chromatography, High Pressure Liquid/methods , Humans , Phytochemicals/pharmacology , Plant Extracts/pharmacology
2.
Rev. bras. farmacogn ; 21(4): 601-607, jul.-ago. 2011. graf, tab
Article in English | LILACS | ID: lil-596243

ABSTRACT

The objective of this study was to show a comparison of the antioxidant properties of aqueous and ethanolic extracts obtained from Baccharis articulata (Lam.) Pers., Baccharis trimera (Less.) DC., Baccharis spicata (Lam.) Baill. and Baccharis usterii Heering, Asteraceae, by several techniques covering a range of oxidant species and of biotargets. We have investigated the ability of the plant extracts to scavenge DPPH (1,1-diphenyl-2-picryl-hydrazyl) free radical, action against lipid peroxidation of membranes including rat liver microsomes and soy bean phosphatidylcholine liposomes by ascorbyl radical and peroxynitrite. Hydroxyl radical scavenger activity was measured monitoring the deoxyribose oxidation. The hypochlorous acid scavenger activity was also evaluated by the prevention of protein carbonylation and finally the myeloperoxidase (MPO) activity inhibition. The results obtained suggest that the Baccharis extracts studied present a significant antioxidant activity scavenging free radicals and protecting biomolecules from the oxidation. We can suggest that the supposed therapeutic efficacy of this plant could be due, in part, to these properties.

3.
Free Radic Res ; 37(5): 555-9, 2003 May.
Article in English | MEDLINE | ID: mdl-12797477

ABSTRACT

Baccharis articulata is traditionally used as diuretic and digestive in local folk medicine of south of Brazil, Uruguay and Argentina. The antioxidant activity of crude ethanol and aqueous extracts, together with ethyl acetate and n-butanol fractions obtained from aqueous extract of B. articulata was determined using TRAP and TBARS assays. The n-butanol fraction was found to be the most active and its major compound (BaII) was isolated, identified and assayed. The structure of the phenolic compound BaII was established by means of spectroscopic and chemical methods as 4'-O-beta-D-glucopyranosyl-3',5'-dimethoxybenzyl-caffeate. This previously unreported metabolite presented similar antioxidant capacity when compared to Trolox.


Subject(s)
Antioxidants/pharmacology , Baccharis/chemistry , Sertoli Cells/cytology , Sesquiterpenes/pharmacology , Animals , Antioxidants/isolation & purification , Chromans/pharmacology , Dose-Response Relationship, Drug , Free Radicals/metabolism , Hydrogen Peroxide/pharmacology , Male , Plant Extracts/chemistry , Plant Extracts/pharmacology , Rats , Sertoli Cells/drug effects , Sertoli Cells/physiology , Thiobarbituric Acid Reactive Substances/metabolism , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...